deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03060512

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

A Phase IV, Randomized, Multi-Center, Open-Label, Prospective, Crossover Study to Evaluate Patient Preference of Movantik™ Versus Polyethylene Glycol 3350 for Opioid-Induced Constipation (OIC) Treatment

Sponsor: AstraZeneca

Updated 10 times since 2017 Last updated: Jul 12, 2018 Started: Mar 2, 2017 Primary completion: Aug 23, 2017 Completion: Aug 23, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03060512, this PHASE4 trial focuses on Opioid Induced Constipation and remains completed. Sponsored by AstraZeneca, it has been updated 10 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Mar 2017 – ~Jul 2017 · 4 months · monthly snapshotRecruiting~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshotRecruiting~Aug 2017 – ~Oct 2017 · 2 months · monthly snapshotRecruiting~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotCompleted~Aug 2018 – ~Jan 2021 · 29 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Aug 2018 — Jan 2021 [monthly]

    Completed PHASE4

Show 5 earlier versions
  1. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE4

  2. Oct 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  3. Aug 2017 — Oct 2017 [monthly]

    Recruiting PHASE4

  4. Jul 2017 — Aug 2017 [monthly]

    Recruiting PHASE4

  5. Mar 2017 — Jul 2017 [monthly]

    Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • QuintilesIMS, Inc.
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .